Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medpace HoldingsMEX:MEDP 95 OCF Yield % is 4.48 as of Jul. 25, 2026, which is 20% below its 10-year median of 5.62. GuruFocus rates MEX:MEDP with a GF Score™ of 95/100 and a GF Value™ of MXN6,131.53. The stock has 2 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Medpace Holdings ranks better than 66.36% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medpace Holdings's OCF Yield % or its related term are showing as below:
MEX:MEDP'
s OCF Yield % Range Over the Past 10 Years
Min: 2.49 Med: 5.62 Max: 9.36
Current: 4.48
During the past 13 years, the highest OCF Yield % of Medpace Holdings was 9.36%. The lowest was 2.49%. And the median was 5.62%.
MEX:MEDP's OCF Yield % is ranked better than 66.36% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.055
vs MEX:MEDP: 4.48
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medpace Holdings OCF Yield % Related Terms
Medpace Holdings OCF Yield % Historical Data
* Premium members only.
The historical data trend for Medpace Holdings's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MEDP vs ICLR, RVTY, CRL: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Medpace Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medpace Holdings OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Medpace Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings (MEX:MEDP) has a OCF Yield % of 4.48 as of Jul. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medpace Holdings and its competitors. This is 20% below median its historical median of 5.62. Over the past decade, Medpace Holdings' OCF Yield % has ranged from 2.49 to 9.36. According to the industry distribution chart, Medpace Holdings ranks #72 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 33.6%.
Is Medpace Holdings' OCF Yield % too high?
Medpace Holdings' current OCF Yield % of 4.48 is 20% below median its 10-year median of 5.62. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 9.36. The Medical Diagnostics & Research industry median OCF Yield % is 1.06. Medpace Holdings' value of 4.48 is 324.6% above this industry median. Based on the distribution chart, Medpace Holdings ranks #72 out of 214 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Medpace Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Medpace Holdings' OCF Yield % compare to ICLR and RVTY?
According to the Medical Diagnostics & Research industry distribution chart, Medpace Holdings ranks #72 out of 214 companies for OCF Yield %. This puts Medpace Holdings in the upper half of its industry. The industry median OCF Yield % is 1.06. Medpace Holdings' value of 4.48 is 324.6% above this benchmark. Historically, Medpace Holdings' own OCF Yield % has ranged from 2.49 to 9.36 over the past decade. While the company's 10-year median is 5.62 vs. the industry median of 1.06, Medpace Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.06, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medpace Holdings's current OCF Yield % of 4.48 is 324.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medpace Holdings and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medpace Holdings's current OCF Yield % is 4.48, which is 20% below median its own 10-year median of 5.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medpace Holdings stock overvalued right now?
Medpace Holdings (MEX:MEDP) has a current OCF Yield % of 4.48. The stock's GF Value™ is MXN6,131.53, compared to a current price of MXN7,022.03 — trading 14.5% above its estimated fair value. The current OCF Yield % is 4.48, which is 20% below median its 10-year median of 5.62 and 324.6% above the Medical Diagnostics & Research industry median of 1.06. Medpace Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Medpace Holdings (MEX:MEDP), the current OCF Yield % is 4.48 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medpace Holdings (MEX:MEDP) Overvalued in 2026?
Based on GuruFocus' analysis, Medpace Holdings stock appears to be overvalued.
The current stock price of MXN7,022.03 is trading 14.5% above its estimated GF Value™ of MXN6,131.53.
Key valuation signals for MEX:MEDP:
OCF Yield %: 4.48 (20% below median its 10-year median of 5.62)
GF Value™: MXN6,131.53 vs. price of MXN7,022.03 (14.5% above fair value)
Industry Position: 324.6% above the Medical Diagnostics & Research median (#72 of 214)
No single metric tells the full story. See the MEX:MEDP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
95GF Score
Get the complete analysis for MEX:MEDP
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MEDP has been successfully added to your 
